General Management of the Patient: Specific Aspects of Infectious Disease Supportive Care in Children-Reference-Cited by-同舟云学术

General Management of the Patient: Specific Aspects of Infectious Disease Supportive Care in Children

Published:2024 Issue: Volume: Page:237-248
ISSN:
Container-title:The EBMT Handbook
language:en
Short-container-title:

Author:

Castagnola Elio,Groll Andreas H.

Abstract

AbstractMany of the conditions requiring allogeneic HCT and related complications are similar in adults and children and are covered in other chapters of this handbook. However, there are a few exceptions where approaches to management can be different.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-44080-9_28

Reference61 articles.

1. Arrieta AC, Sung L, Bradley JS, et al. A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia. PLoS One. 2019;14:e0212837.

2. Arrieta AC, Neely M, Day C, et al. Safety, tolerability and population pharmacokinetics of intravenous and oral isavuconazolium sulfate in pediatric patients. Antimicrob Agents Chemother. 2021;65:e00290–21.

3. Bernhard S, Kernland Lang K, Ammann RA, et al. Voriconazole-induced phototoxicity in children. Pediatr Infect Dis J. 2012;31:769–71.

4. Castagnola E, Mesini A. Antifungal prophylaxis in children receiving antineoplastic chemotherapy. Curr Fungal Infect Rep. 2018;12:78–85.

5. Castagnola E, Bagnasco F, Amoroso L, et al. Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant: a single center 30-year experience. Pediatr Infect Dis J. 2014a;33:233–7.